AMACR and metastatic prostate carcinoma: In this paper, we explore the expression of two proteins, i.e. EZH2 and AMACR known to be differentially expressed in non aggressive or localized tumors (class 1 or negative class) versus aggressive or metastatic prostate cancers (class 2 or positive class).